Arax Advisory Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Sell |
2,572
-51
| -2% | -$19.5K | 0.05% | 258 |
|
|
2025
Q1 | $906K | Sell |
2,623
-1,189
| -31% | -$411K | 0.06% | 198 |
|
|
2024
Q4 | $1.14M | Buy |
3,812
+1,929
| +102% | +$579K | 0.07% | 163 |
|
|
2024
Q3 | $765K | Sell |
1,883
-37
| -2% | -$15K | 0.07% | 141 |
|
|
2024
Q2 | $617K | Buy |
1,920
+180
| +10% | +$57.8K | 0.06% | 156 |
|
|
2024
Q1 | $580K | Buy |
1,740
+72
| +4% | +$24K | 0.06% | 146 |
|
|
2023
Q4 | $451K | Buy |
1,668
+476
| +40% | +$129K | 0.05% | 170 |
|
|
2023
Q3 | $293K | Sell |
1,192
-28
| -2% | -$6.89K | 0.04% | 209 |
|
|
2023
Q2 | $370K | Buy |
1,220
+26
| +2% | +$7.89K | 0.05% | 160 |
|
|
2023
Q1 | $315K | Sell |
1,194
-10
| -0.8% | -$2.64K | 0.04% | 177 |
|
|
2022
Q4 | $289K | Sell |
1,204
-62
| -5% | -$14.9K | 0.04% | 182 |
|
|
2022
Q3 | $233K | Buy |
1,266
+74
| +6% | +$13.6K | 0.04% | 189 |
|
|
2022
Q2 | $200K | Buy |
1,192
+77
| +7% | +$12.9K | 0.03% | 216 |
|
|
2022
Q1 | $280K | Sell |
1,115
-10
| -0.9% | -$2.51K | 0.04% | 196 |
|
|
2021
Q4 | $289K | Buy |
1,125
+17
| +2% | +$4.37K | 0.04% | 191 |
|
|
2021
Q3 | $269K | Sell |
1,108
-182
| -14% | -$44.2K | 0.04% | 201 |
|
|
2021
Q2 | $267K | Buy |
+1,290
| New | +$267K | 0.04% | 204 |
|
|
2020
Q4 | $216K | Sell |
1,315
-22
| -2% | -$3.61K | 0.03% | 199 |
|
|
2020
Q3 | $167K | Buy |
1,337
+360
| +37% | +$45K | 0.03% | 210 |
|
|
2020
Q2 | $95K | Buy |
977
+332
| +51% | +$32.3K | 0.02% | 269 |
|
|
2020
Q1 | $58K | Buy |
+645
| New | +$58K | 0.01% | 306 |
|
|
2018
Q3 | – | Sell |
-505
| Closed | -$51K | – | 661 |
|
|
2018
Q2 | $51K | Buy |
505
+11
| +2% | +$1.11K | 0.02% | 211 |
|
|
2018
Q1 | $47K | Sell |
494
-2
| -0.4% | -$190 | 0.02% | 207 |
|
|
2017
Q4 | $43K | Buy |
496
+11
| +2% | +$954 | 0.02% | 224 |
|
|
2017
Q3 | $38K | Sell |
485
-749
| -61% | -$58.7K | 0.02% | 237 |
|
|
2017
Q2 | $108K | Buy |
1,234
+406
| +49% | +$35.5K | 0.05% | 149 |
|
|
2017
Q1 | $73K | Buy |
828
+424
| +105% | +$37.4K | 0.04% | 158 |
|
|
2016
Q4 | $30K | Buy |
+404
| New | +$30K | 0.02% | 220 |
|